Correlation Between Pentair PLC and Traws Pharma

Can any of the company-specific risk be diversified away by investing in both Pentair PLC and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pentair PLC and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pentair PLC and Traws Pharma, you can compare the effects of market volatilities on Pentair PLC and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pentair PLC with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pentair PLC and Traws Pharma.

Diversification Opportunities for Pentair PLC and Traws Pharma

-0.33

Correlation Coefficient

Pentair PLC  Traws Pharma

Very good diversification

The 3 months correlation between Pentair and Traws is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pentair PLC and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Pentair PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pentair PLC are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Pentair PLC i.e., Pentair PLC and Traws Pharma go up and down completely randomly.

Pair Corralation between Pentair PLC and Traws Pharma

Considering the 90-day investment horizon Pentair PLC is expected to generate 15.92 times less return on investment than Traws Pharma. But when comparing it to its historical volatility, Pentair PLC is 17.89 times less risky than Traws Pharma. It trades about 0.09 of its potential returns per unit of risk. Traws Pharma is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  496.00  in Traws Pharma on October 25, 2024 and sell it today you would earn a total of  99.00  from holding Traws Pharma or generate 19.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pentair PLC  vs.  Traws Pharma

Pentair PLC

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pentair PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Pentair PLC may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Traws Pharma

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Traws Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Traws Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pentair PLC and Traws Pharma

The main advantage of trading using opposite Pentair PLC and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pentair PLC position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.

The idea behind Pentair PLC and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.